As Per the Report, the Perfusion Systems Market Size in Latin America is valued at USD 0.07 billion in 2023 and estimated to grow at a CAGR of 2%, to reach USD 0.08 billion by 2028 during the forecast period 2023 to 2028. The Latin America Perfusion Systems market is developing relatively slowly.
The term "perfusion" is derived from the French verb 'perfuse' meaning to 'pour over or through'. Perfusionists employ artificial blood pumps to push open-heart surgery patients' blood via their body tissue, replacing the function of the heart while the cardiac surgeon operates. When a patient's blood is continuously removed and returned through plastic tubing to allow health care professionals to perform an artificial organ function on the blood, it is called "extra-corporeal circulation (ECC)" - outside the body blood circulation
The crucial factor driving the growth of this market is Growth in Aging Population, Increasing Incidence of Multiple Organ Failures in developed as well as developing further propels the growth of this market. Government and NGO Initiatives to Encourage Organ Donation also further drive market growth. The limiting factors for market growth are high costs, cumbersome regulatory procedures and stringent rules of compliance. Also, tough competition from local companies with low cost products is hampering the growth of this market.
The market is anticipated to keep thriving in both created and creating districts. The development is additionally credited to the developing interest in perfusion systems.
This research report on the Latin America Perfusion Systems Market has been segmented and sub-segmented into the following categories
On the basis of type, the bioreactor perfusion systems segment holds the major share of the perfusion systems market in 2018 and is projected to record the highest CAGR during the forecast period.
Noteworthy Companies dominating the Latin America Perfusion Systems Market Profiled in the Report are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories, Inc, Merck KGaA, Harvard Bioscience, Inc, ALA Scientific Instruments, Inc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org